Medical Equipment

Renal Denervation Devices Market Revenue Growth Expected to Reach $3 Billion by 2030 with 32.4% CAGR

March 17, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Renal Denervation Devices Market In 2026 And What Value Is Projected For 2030?

The renal denervation devices market size has witnessed substantial expansion in recent years. It is anticipated to expand from $0.74 billion in 2025 to $0.98 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 32.5%. The market’s past growth can be attributed to an increase in the prevalence of resistant hypertension, improvements in catheter ablation technologies, intensified clinical research within renal denervation, the expansion of interventional cardiology procedures, and heightened awareness of non-pharmacological treatments for hypertension.

The renal denervation devices market size is forecast to undergo significant expansion in the upcoming years. It is predicted to reach $3.01 billion in 2030, with a compound annual growth rate (CAGR) of 32.4%. The increase during the projection period can be attributed to a rise in regulatory approvals for renal denervation devices, greater implementation in outpatient settings, an escalating demand for long-term hypertension management solutions, the expansion of clinical evidence supporting efficacy, and increased investment in next-generation ablation systems. Prominent trends expected in the forecast period include a growing acceptance of catheter-based hypertension therapies, wider application of radiofrequency and ultrasound ablation technologies, an increasing focus on minimally invasive cardiovascular interventions, the proliferation of image-guided renal denervation procedures, and a stronger emphasis on procedure safety and precision.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10631&type=smp

What Drivers Are Influencing The Renal Denervation Devices Market?

The anticipated rise in the occurrence of hypertension is projected to fuel the expansion of the renal denervation devices market going forward. Hypertension, commonly referred to as high blood pressure, is a medical state characterized by persistently elevated blood flow pressure within the blood vessels. Renal denervation, a procedure utilizing catheters, has emerged as a promising treatment approach for individuals suffering from resistant hypertension. This procedure is a minimally invasive and experimental method for managing hypertension that has proven unresponsive to conventional medication. As an illustration, the Centers for Disease Control and Prevention, a government body based in the US, reported in January 2025 that high blood pressure was a contributing factor or direct cause of 664,470 fatalities in the United States during 2023. Consequently, the growing prevalence of hypertension is expected to stimulate the advancement of the renal denervation devices market.

What Are The Key Segments Of The Renal Denervation Devices Market?

The renal denervation devices market covered in this report is segmented –

1) By Product: Simplicity Renal Denervation System, EnligHTN, Vessix Renal Denervation System, Iberis Renal Sympathetic Denervation System, Paradise Renal Denervation System, Other Products

2) By Technology: Radio Frequency Ablation, Ultrasound Energy-Based RDN, Other Technologies

3) By End-Users: Hospitals, Cardiovascular research centre, Other End-Users

Subsegments:

1) By Simplicity Renal Denervation System: Catheter System, Accessories

2) By EnligHTN: Catheter System, Generator, Accessories

3) By Vessix Renal Denervation System: Balloon Catheter, Generator, Accessories

4) By Iberis Renal Sympathetic Denervation System: Catheter System, Accessories

5) By Paradise Renal Denervation System: Catheter System, Accessories

6) By Other Products: Emerging Technologies, Alternative Devices

What Key Trends Are Influencing The Development Of The Renal Denervation Devices Market?

Leading companies within the renal denervation devices market are prioritizing the development of ultrasound renal denervation (uRDN) to improve treatment efficacy, lessen procedural complications, and offer a non-invasive option compared to traditional renal denervation methods. Ultrasound renal denervation (uRDN) elevates renal denervation devices by facilitating accurate, non-invasive energy delivery to renal nerves, thereby effectively reducing blood pressure while safeguarding adjacent tissues, and boosting patient safety and comfort during the process. For instance, in November 2023, Recor Medical Inc., a US-based medical technology company, introduced the Paradise uRDN system, an inventive ultrasound renal denervation device engineered to manage hypertension in individuals who have not reached blood pressure objectives through standard lifestyle modifications and medications. Equipped with hydrocooling technology to protect the renal artery during treatment, this system marks a substantial stride in the renal denervation devices market by providing a fresh, nonpharmacologic method for controlling resistant hypertension and broadening the spectrum of treatment alternatives for patients.

Who Are The Leading Companies Operating In The Renal Denervation Devices Market?

Major companies operating in the renal denervation devices market are Medtronic PLC, ReCor Medical Inc., Boston Scientific Corporation, Abbott Laboratories, Cordis Corporation, Terumo Corporation, Kona Medical Inc., St. Jude Medical LLC, Johnson & Johnson, Symple Surgical Inc., Cardiosonic Ltd., Mercator MedSystems Inc., Ablative Solutions Inc., Renal Dynamics Ltd., Vesalio LLC, Biotronik SE & Co. KG, Cook Medical LLC, Hansen Medical Inc., Merit Medical Systems Inc., AngioDynamics Inc., Covidien Ltd., Volcano Corporation

Read the full renal denervation devices market report here:

https://www.thebusinessresearchcompany.com/report/renal-denervation-devices-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Renal Denervation Devices Market?

Europe was the largest region in the renal denervation devices market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global renal denervation devices market report during the forecast period. The regions covered in the renal denervation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Renal Denervation Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10631&type=smp

Browse Through More Reports Similar to the Global Renal Denervation Devices Market 2026, By The Business Research Company

Nephrology And Urology Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/nephrology-and-urology-devices-global-market-report

Late Stage Chronic Kidney Disease Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/late-stage-chronic-kidney-disease-drugs-global-market-report

Kidney Stone Retrieval Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-stone-retrieval-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795